Trials / Conditions / Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
7 registered clinical trials studyying Sodium-Glucose Transporter 2 Inhibitors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients NCT07143773 | Odense University Hospital | Phase 4 |
| Active Not Recruiting | Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension NCT06933355 | Odense University Hospital | Phase 4 |
| Unknown | Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Dise NCT05975528 | Yonsei University | Phase 4 |
| Completed | Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome NCT06026787 | Ain Shams University | Phase 4 |
| Completed | Empagliflozin in Diuretic Refractory Ascites NCT05013502 | Stanford University | Phase 1 |
| Completed | Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Die NCT06383832 | Sun Jia | Phase 4 |
| Completed | Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production NCT03852901 | National Institute on Aging (NIA) | Phase 1 |